<table border="1" id="i4bd792ea-979b-4dff-85d6-05ba5f91d939" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<th>
<br/>
</th>
<th> Caffeine Citrate<br/>
</th>
<th> Placebo<br/>
</th>
<th> p-value<br/>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>Number of patients evaluated*</td>
<td>45<br/>
</td>
<td>37<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>% of patients with zero apnea events on day 2<br/>
</td>
<td>26.7<br/>
</td>
<td>8.1<br/>
</td>
<td>0.03<br/>
</td>
</tr>
<tr>
<td>Apnea rate on day 2 (per 24 hrs.)<br/>
</td>
<td>4.9<br/>
</td>
<td>7.2<br/>
</td>
<td>0.134<br/>
</td>
</tr>
<tr>
<td>% of patients with 50% reduction in apnea events from baseline on day 2<br/>
</td>
<td>76<br/>
</td>
<td>57<br/>
</td>
<td>0.07<br/>
</td>
</tr>
<tr>
<td colspan="4">* Of 85 patients who received drug, 3 were not included in the efficacy analysis because they had &lt;6 apnea episodes/24 hours at baseline.</td>
</tr>
</tbody>
</table>